CureDuchenne to bring in Brenda Wong
USA-based non-profit CureDuchenne has announced the appointment of Brenda Wong (pictured above) as its new chief medical advisor (CMA), effective January 5, 2026.
A nationally-recognized authority in neuromuscular medicine and clinical research, Dr Wong has spent her career caring for those living with Duchenne and Becker muscular dystrophy.
With more than 20 years of experience in pediatrics and 25 years in pediatric neurology, Dr Wong directed the Comprehensive Neuromuscular Center at Cincinnati Children’s Hospital Medical Center for 19 years before relocating to Massachusetts in 2018 to become founding director of the Duchenne Muscular Dystrophy Center at the University of Massachusetts Memorial Medical Center, and professor of pediatrics and neurology at the University of Massachusetts Chan Medical School.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze